Acknowledgements and Disclosures

The SENSCIS and SENSCIS-ON trials were funded by Boehringer Ingelheim International GmbH (BI). The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors did not receive payment for the development of this poster. Editorial support and formatting assistance were provided by Julie Fleming and Wendy Morris of FleishmanHillard, London, UK, which was contracted and funded by BI. BI was given the opportunity to review the poster for medical and scientific accuracy as well as intellectual property considerations.

KBH reports grants and fees from Actelion, BI and United Therapeutics, fees from Bayer, and grants from Genentech, Eiger, Reata. YA reports grants and fees from Inventiva and Sanofi, and fees from Bayer, BI, ChemomAb, Roche/Genentech.